Evaluation of disease‐free survival as an intermediate metric of overall survival in patients with localized renal cell carcinoma: A trial‐level meta‐analysis

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|124|5|925-933

ISSN： 0008-543x

Source： CANCER, Vol.124, Iss.5, 2018-03, pp. : 925-933

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Plasma fibrinogen level: an independent prognostic factor for disease‐free survival and cancer‐specific survival in patients with localised renal cell carcinoma

By  

BJU INTERNATIONAL, Vol. 118, Iss. 4, 2016-10 ,pp. : 598-603

John Wiley & Sons Inc

Access to resources Recommend Favorite

Progression‐free survival as a surrogate endpoint of overall survival in patients with metastatic renal cell carcinoma

By  

CANCER, Vol. 120, Iss. 1, 2014-01 ,pp. : 52-60

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognostic Nomogram for Disease-Free Survival in Patients with Renal Adenocarcinoma

By  

Urologia Internationalis, Vol. 88, Iss. 3, 2012-02 ,pp. : 271-276

Karger

Access to resources Recommend Favorite

Relationship between Treatment Effects on Progression-Free Survival and Overall Survival in Multiple Myeloma: A Systematic Review and Meta-Analysis of Published Clinical Trial Data

By  

Oncology Research and Treatment, Vol. 38, Iss. 3, 2015-02 ,pp. : 88-94

Karger

Access to resources Recommend Favorite

Postoperative Hyperprolactinemia Could Predict Longer Disease-Free and Overall Survival in Node-Negative Breast Cancer Patients

By  

Oncology, Vol. 63, Iss. 4, 2002-11 ,pp. : 370-377

Karger

Access to resources Recommend Favorite